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A powerful method for analyzing ligand binding specificity in
receptor chimeras, introduced by Catterall ( 1), holds great
promise for localizing the determinants ofligand binding speci-
ficity. Applying this method to data from chimeras ofa2-adren-
ergic and 32-adrenergic receptors (2) lead to the conclusion
that determinants of specificity reside predominantly on trans-
membrane segment 7. However, the following considerations,
many ofwhich have general importance in the analysis ofbind-
ing data, lead to different conclusions.
The analysis makes use of agonist dissociation constants (Kd
measured in reference 2 by displacement ofradiolabeled antag-
onist) to compute a difference in the binding free energy
(A( AG)) oftwo different ligands to the same receptor. Catterall
(1) plotted A( AG) values for the drug pair p-aminoclonidine
(PAC) and isoproternal (ISO) versus the number of segments
from the a2-adrenergic receptor (Fig. 1). However, a point at
coordinates [ 1, 0.08 ] appears to have been based on EC50 mea-
surements of Kobilka et al. (2) rather than Kd measurements.
No Kd measurements were made for this chimera (CR6 ofrefer-
ence 2). Kd values and EC50 values should not be plotted to-
gether because in G-protein-coupled receptors they are gener-
ally divergent (3), and for this particular system differed by a
factor of up to 50 (2). Furthermore, a dose-response curve for
CR6 had only two nonzero points, and showed no saturation
(2). Without the point for chimera CR6, the data for the other
three chimeras with segment 7 from the a2-adrenergic receptor
do not extend over a sufficiently broad range to justify Catter-
all's conclusion that the other segments each contribute 0.8
kcal/ mol to the difference in binding energy between PAC and
ISO. A case for dominance by segment 7 can still be made for
the selectivity between PAC and ISO because ofthe large jump
at n = 5 of Fig. 1 (2).
A plot of A( AG) for PAC and epinephrine (EPI) leads one to
a different conclusion (Fig. 1). Although EPI activates both
receptors, the plot exhibits a clear transition from O2 character
to a2 character. The transition is gradual, with no sharp jump
for any one transmembrane segment replacement. Thus, this
plot suggests a distribution of determinants of specificity over
many regions of the receptor.
A shift in the binding-site saturation behavior ofan allosteric
protein need not result from a change at the binding site. A
change in the free energy difference between the two protein
conformations can also shift a binding-site saturation curve
(4). Consider the binding-site saturation function given by the
Monod-Wyman-Changeux theory for a one-site receptor:
C(1 +RI)
K,( + RO) + C(1 + RI)'
where C denotes concentration of ligand, Ro and R1 denote the
equilibrium concentration ratios ofthe active and inactive con-
formations of the unligated and ligated receptors, respectively,
and K1 denotes the dissociation constant for binding to the
inactive conformation. What is taken as Kd is then actually
K1(l + RO)/(1 + R1). Ro and R1 depend on regions of the
protein away from the binding site. Thus, a change in the appar-
ent Kd could result from changes far from the binding site,
leaving an ambiguity in how to interpret a change in Kd.
Catterall's proposal of using A( AG) is a step towards over-
coming this problem. Taking the difference oftwo free energies
requires taking the ratio of the two apparent Kd's. For a true
agonist R»> 1. This gives 1 + R1 - RI, which together with the
condition of detailed balance reduces the apparent Kd to
K2( 1 + RO)/RO (K2 denotes the dissociation constant for the
active receptor conformation). Since Ro depends only on pro-
tein and not agonist, taking the ratio of two apparent Kd's for
the same protein cancels out the Ro containing terms to leave a
ratio of K2's. For antagonists, R1 - 0, and a similar cancella-
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FIGURE I A( AG) plotted versus the number of transmembrane seg-
ments from the a2-adrenergic receptor. Gibbs free energies of ligand
binding were calculated from the Kd values reported by Kobilka et al.
(2). The difference between binding free energies was then computed
for the drug pairs PAC and ISO (squares) and PAC and EPI (circles). A
point at n = 1 was based on EC50 measurements for PAC and ISO
activation of chimera CR6 (open square). The dashed line divides the
Kd data into two groups ofchimeras, with segment 7 either from the f2
receptor (above, left) or from the a2 receptor (below, right). The recep-
tors from which the various segments were taken is indicated below the
x-axis.
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tion occurs to leave a ratio of K,'s. Thus, in comparisons
among agonists or among antagonists, A( AG) is a useful quan-
titative index of binding site function. These considerations
should help investigators use binding data to localize function
in molecular variants of receptors.
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